{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17346078", "DateCompleted": {"Year": "2007", "Month": "05", "Day": "02"}, "DateRevised": {"Year": "2007", "Month": "12", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2007", "Month": "03", "Day": "09"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "70", "Issue": "3", "PubDate": {"Year": "2007", "Month": "Mar"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Antineoplastic agents. 550. Synthesis of 10b(s)-epipancratistatin from (+)-narciclasine.", "Pagination": {"StartPage": "417", "EndPage": "422", "MedlinePgn": "417-22"}, "Abstract": {"AbstractText": ["By means of a five-step reaction sequence, narciclasine (2a), isolated from Narcissus sp., was converted to 10b(S)-epipancratistatin (3a) in 5.7% overall yield. The key step entailed a radical-initiated 10b,1 C-O cleavage employing tributyltin hydride to yield a B/C cis ring juncture (3b). Biological evaluation of 10b(S)-epipancratistatin (3a) provided evidence that antineoplastic activity was reduced by a factor of 10 when the B/C trans juncture was replaced with a B/C cis ring juncture."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 872404, Tempe, AZ 85287-2404, USA. bpettit@asu.edu"}], "Identifier": [], "LastName": "Pettit", "ForeName": "George R", "Initials": "GR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Melody", "ForeName": "Noeleen", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Herald", "ForeName": "Delbert L", "Initials": "DL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Knight", "ForeName": "John C", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chapuis", "ForeName": "Jean-Charles", "Initials": "JC"}], "GrantList": [{"GrantID": "R01 CA 90441-01-05", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "10b(s)-epipancratistatin"}, {"RegistryNumber": "0", "NameOfSubstance": "Amaryllidaceae Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenanthridines"}, {"RegistryNumber": "29477-83-6", "NameOfSubstance": "narciclasine"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Amaryllidaceae Alkaloids"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Narcissus"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Phenanthridines"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "3", "Day": "10", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "5", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "3", "Day": "10", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17346078", "10.1021/np068046e"]}}], "PubmedBookArticle": []}